Jing Cai

3.7k citations
108 papers · 2.4k indexed · h-index 28
Topics
Lung Cancer Treatments and Mutations (13 papers)Lung Cancer Diagnosis and Treatment (10 papers)Cancer-related molecular mechanisms research (8 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaNano Letters
Partner nations
ChinaUnited StatesFrance

In The Last Decade

Jing Cai

103 papers receiving 2.4k citations

Peers

Jing Cai
Comparison fields: 5 of 136
  • Molecular Biology 1.2k
  • Cancer Research 721
  • Oncology 406
  • Pulmonary and Respiratory Medicine 291
  • Biomedical Engineering 254
Replace Noushin Nabavi with:
Noushin Nabavi Canada
Peng Sun China
Ana Bela Sarmento‐Ribeiro Portugal
Liming Wang China
Yitao Ding China
Karuppaiyah Selvendiran United States
Chunxiao Zhou United States
Xuefeng Wang China
Reza Bayat Mokhtari Canada
Yingjie Xu China
Jing Cai relative to Noushin Nabavi Canada Noushin Nabavi's profile →
Citations per field
00.5×3.5×
Noushin Nabavi · 1×
Citations per year

Countries citing papers authored by Jing Cai

Since Specialization
Citations

This map shows the geographic impact of Jing Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Cai more than expected).

Fields of papers citing papers by Jing Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Cai. The network helps show where Jing Cai may publish in the future.

Co-authorship network of co-authors of Jing Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Cai. A scholar is included among the top collaborators of Jing Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Cai. Jing Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 5
4 3
5 0
6 10
7 2
8 66
9 10
10 36
11 24
12 9
13 10
14 49
15 27
16 28
17 27
18 16
19 87
20 38

About Jing Cai

Jing Cai is a scholar working on Cancer Research, Oncology and Biomaterials, having authored 108 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (721 citations), Molecular Biology (1.2k citations) and Oncology (406 citations). Jing Cai has collaborated with scholars based in China, United States and France. Frequent co-authors include Bo Xiang, Mei Yi, Guiyuan Li, Zhaoyang Zeng, Xiaoling Li, Yixin Tan, Wei Xiong, Anwen Liu, Yuanyuan Ban and Anwen Liu. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Nano Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026